16 research outputs found

    СОВРЕМЕННАЯ КОНЦЕПЦИЯ ЦИФРОВОЙ ИДЕНТИФИКАЦИИ АВИАПАССАЖИРОВ

    Get PDF
    The article presents the main provisions of the digital passenger identification concept based on the use of blockchain technology. It is summarized that the introduction of secure biometric identification of passengers at the airport will reduce the time and financial costs associated with the inspection and going through the passport and customs control. The problematic aspects of the current legislation of the Russian Federation regulating the application of this technology are analyzed. The technology Smart Path, developed by SITA is considered. The essence of this technology is the use of biometric data as a single identification taken at each stage of the journey. The possibilities of using blockchain technology as the basis of passenger identification before the departure are analyzed, while the blockchain technology eliminates the need for centralized processing and storage of personal data of air passengers. A computer science dealing with the chain of blocks based on the cryptosystem ensures the confidentiality of data and the absence of the possibility of information leakage or misuse. It is specially noted that the technology of cryptographic protection of air passengers biometric data will become an obstacle to using personal information for illegal purposes, and the capabilities of blockchain technology will allow cross-border data exchange during international flights. It is concluded that with the use of this technology, there will be no need to maintain the staff of workers responsible for document verification and control over the identification of passengers. All these functions will be replaced by a distributed database, which cannot be destroyed or hacked. On the basis of the study, it is proposed to amend the current legislation regulating the procedure for collecting and processing the personal data of airline passengers.В статье представлены основные положения концепции цифровой идентификации пассажиров авиарейсов, основанной на использовании технологии blockchain (блокчейн). Резюмируется, что внедрение защищенной биометрической идентификации пассажиров в аэропорту снизит временные и финансовые затраты, связанные с досмотром и прохождением паспортного и таможенного контроля. Анализируются проблемные аспекты действующего законодательства РФ, регламентирующего применение указанной технологии. Рассматривается технология Smart Path, разработанная компанией SITA, суть которой заключается в использовании биометрических данных как единого идентификационного токена на каждом этапе путешествия. Исследуются возможности применения технологии блокчейн в основе идентификации пассажиров перед вылетом, при этом технология блокчейн устраняет необходимость в централизованной обработке и хранении персональных данных авиапассажиров. Основанная на криптосистеме компьютерная наука о цепочке блоков обеспечивает конфиденциальность данных и отсутствие возможности утечки сведений или их нецелевого использования. Особо отмечается, что технология криптографической защиты биометрических данных авиапассажиров станет препятствием для использования персональной информации в противоправных целях, а возможности технологии блокчейн позволят производить трансграничный обмен данными во время международных перелетов. Делается вывод, что с применением этой технологии исчезнет потребность в содержании штата работников, отвечающих за проверку документов и контроль за идентификацией пассажиров. Все эти функции заменит распределенная база данных, которую невозможно уничтожить или взломать. На основе проведенного исследования предлагается внести изменения в действующее законодательство, регламентирующее процедуру сбора и обработки персональных данных пассажиров авиарейсов

    ВТОРИЧНАЯ ПРОФИЛАКТИКА СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ, АССОЦИИРОВАННЫХ С ТРЕВОЖНЫМИ И ДЕПРЕССИВНЫМИ РАССТРОЙСТВАМИ: ПУТИ ОПТИМИЗАЦИИ

    Get PDF
    Somatic and psychological risk factors (RF) were studied in 835 patients with arterial hypertension (AH) and ischemic heart disease (IHD) who had been admitted to the Borderline Department of MHRI SB RAMS for severity of neurotic and affective disorders provoked by previous psychosomatic events (psychosocial stress). Earlier the patients had been under control of cardiologists and therapists in general medical institutions. Systemic analysis of interrelation between somatic, psychic, and psychosocial factors defining the mechanisms of psychosomatic correlation formation in the patients with CVD with depressive disorders was applied.На клиническом материале, включающем 835 пациентов с артериальной гипертонией и ишемической болезнью сердца, госпитализированных в отделение пограничных состояний НИИПЗ СО РАМН в связи с выраженностью невротических и аффективных расстройств, обусловленных предшествующими психотравмирующими событиями (психосоциальным стрессом), изучены соматические и психосоциальные факторы риска. Ранее пациенты наблюдались в общемедицинских учреждениях у кардиолога или терапевта. В исследовании применен системный анализ взаимосвязи соматических, психических, психосоциальных факторов, определяющий механизмы формирования психосоматических соотношений у больных сердечно-сосудистыми заболеваниями с тревожными и депрессивными расстройствами для оценки кардиоваскулярного риска и выбора стратегии вторичной профилактики в общемедицинской практике

    Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study

    Get PDF
    Objectives Mortality among HIV patients with tuberculosis (TB) remains high in Eastern Europe (EE), but details of TB and HIV management remain scarce. Methods In this prospective study, we describe the TB treatment regimens of patients with multi-drug resistant (MDR) TB and use of antiretroviral therapy (ART). Results A total of 105 HIV-positive patients had MDR-TB (including 33 with extensive drug resistance) and 130 pan-susceptible TB. Adequate initial TB treatment was provided for 8% of patients with MDR-TB compared with 80% of those with pan-susceptible TB. By twelve months, an estimated 57.3% (95%CI 41.5\u201374.1) of MDR-TB patients had started adequate treatment. While 67% received ART, HIV-RNA suppression was demonstrated in only 23%. Conclusions Our results show that internationally recommended MDR-TB treatment regimens were infrequently used and that ART use and viral suppression was well below the target of 90%, reflecting the challenging patient population and the environment in which health care is provided. Urgent improvement of management of patients with TB/HIV in EE, in particular for those with MDR-TB, is needed and includes widespread access to rapid TB diagnostics, better access to and use of second-line TB drugs, timely ART initiation with viral load monitoring, and integration of TB/HIV care

    MODERN CONCEPT OF DIGITAL IDENTIFICATION OF AIR PASSENGERS

    No full text
    The article presents the main provisions of the digital passenger identification concept based on the use of blockchain technology. It is summarized that the introduction of secure biometric identification of passengers at the airport will reduce the time and financial costs associated with the inspection and going through the passport and customs control. The problematic aspects of the current legislation of the Russian Federation regulating the application of this technology are analyzed. The technology Smart Path, developed by SITA is considered. The essence of this technology is the use of biometric data as a single identification taken at each stage of the journey. The possibilities of using blockchain technology as the basis of passenger identification before the departure are analyzed, while the blockchain technology eliminates the need for centralized processing and storage of personal data of air passengers. A computer science dealing with the chain of blocks based on the cryptosystem ensures the confidentiality of data and the absence of the possibility of information leakage or misuse. It is specially noted that the technology of cryptographic protection of air passengers biometric data will become an obstacle to using personal information for illegal purposes, and the capabilities of blockchain technology will allow cross-border data exchange during international flights. It is concluded that with the use of this technology, there will be no need to maintain the staff of workers responsible for document verification and control over the identification of passengers. All these functions will be replaced by a distributed database, which cannot be destroyed or hacked. On the basis of the study, it is proposed to amend the current legislation regulating the procedure for collecting and processing the personal data of airline passengers

    METHOD AND MEANS OF ANXIETY-DEPRESSION DISORDERS CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH 2ND TYPE DIABETES

    Get PDF
    Aim. To elaborate the method and means for correction of anxiety-depression disorders in patients with arterial hypertension (AH) associated with 2nd type diabetes mellitus.Material and methods. Totally 120 patients included with essential arterial hypertension (AH), associated with 2nd type DM, non-sufficient control of В P. Patients with AH had the second grade of BP increase at the background of 2nd type DM of mild or moderate severity compensated according to the levels of glycosilated hemoglobin 6,25%. Patients had quite high amount of comorbidities and risk factors complicating AH. All patients were taking basic ant hypertension therapy, mostly a variety of combinations of drugs (beta-blockers, ACE inhibitors, calcium antagonists,angiotensine receptor blockers II). Also the patients took the drugs for comorbidities treatment (hypolipidemic drugs, nitrates, glucose lowering drugs). The necessary criteria was patients' consent.In outpatient conditions, at the 1st visit and in 1 year we performed a complex of events: anamnesis collection, clarification of complaints; palpation and auscultation of the heart and main vessels; BP measurement by Korotkov on upper extremities; ECG recording, echocardiography. Biochemical analysis of the whole plasma was done, fasting: we measured glucose level, glycosilated hemoglobin, lipid spectrum (cholesterol, triglycerides, LDL, HDL), clotting system parameters (PI, APTT, fibrinogen), electrolites (K, Mg). Also patients by themselves completed medical questionnaires of a special purpose. We used HADS questionnaire and self-assessment for depressions CED-S. If the increased levels of anxiety and depression were found we prescriben Qudesan® — mitochondrial coenzyme — coenzyme Q10 in dose 60 mg daily for 2 months. The dosage was calculated according to the drug sheet.Results. The data we collected witnesses that clinical efficacy was reached in patients at the background of Qudesan® intake: significantly positively changed psychological status of patients — depression decreased by the scales of specialized questionnaires. Scoring of the influence of that drug was done by comparison of clinical characteristics after treatment. Before treatment the parameters studied were identical that is also confirmed by the absence of significance of their difference (p>0,01).Conclusion. The study led to obtainment of a new data on that inclusion of Q10 containing drug into the standard treatment of AH with 2nd type DM has positive clinical effect that, particularly, leads to a significant decrease of systolic and diastoiic blood pressure, significant decrease of BP variability, significant decrease of blood glucose levels and glycosilated hemoglobin, significant increase of Mg level in blood. Also the positive influence of complex therapy noted on the decrease of anxiety and depression level in patients with AH and DM 2 type

    Secondary prophylaxis of cardiovascular diseasses associated with anxiety and depressive disorders: ways of optimization

    No full text
    Somatic and psychological risk factors (RF) were studied in 835 patients with arterial hypertension (AH) and ischemic heart disease (IHD) who had been admitted to the Borderline Department of MHRI SB RAMS for severity of neurotic and affective disorders provoked by previous psychosomatic events (psychosocial stress). Earlier the patients had been under control of cardiologists and therapists in general medical institutions. Systemic analysis of interrelation between somatic, psychic, and psychosocial factors defining the mechanisms of psychosomatic correlation formation in the patients with CVD with depressive disorders was applied

    ВТОРИЧНАЯ ПРОФИЛАКТИКА СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ, АССОЦИИРОВАННЫХ С ТРЕВОЖНЫМИ И ДЕПРЕССИВНЫМИ РАССТРОЙСТВАМИ: ПУТИ ОПТИМИЗАЦИИ

    No full text
    Somatic and psychosomatic risk factors (RF) were studied in 835 patients with arterial hypertension (AH) and ischemic heart disease who had been admitted to the Department of Borderline conditions of MHRI for severity of neurotic and affective disorders provoked by previous psycho-traumatic events (psychosocial stress). Earlier the patients had been under medical supervision of cardiologists or therapeutists at general medicine institutions. Systemic analysis of correlation between somatic, psychic and psycho-social factors responsible for the mechanisms of formation of psychosomatic correlation in the CVD patients with anxiety and depressive disorders in order to estimate the cardiovascular risk and to choose the strategy of the secondary prophylaxis available in the general medicine practice.На клиническом материале, включающем 835 пациентов с артериальной гипертонией (АГ) и ишемической болезнью сердца (ИБС), госпитализированных в отделения пограничных состояний НИИПЗ СО РАМН в связи с выраженностью невротических и аффективных расстройств, обусловленных предшествующими психотравмирующими событиями (психосоциальным стрессом), изучены соматические и психосоциальные факторы риска (ФР). Ранее пациенты наблюдались в общемедицинских учреждениях у кардиолога или терапевта. В исследовании применен системный анализ взаимосвязи соматических, психических, психосоциальных факторов, определяющий механизмы формирования психосоматических соотношений у больных ССЗ с тревожными и депрессивными расстройствами для оценки кардиоваскулярного риска и выбора стратегии вторичной профилактики в общемедицинской
    corecore